<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and Hispanic patients versus non-Hispanic White patients, according to a study published online Sept. 25 in JAMA Network Open<\/i>.<\/p>\n
Rafi Kabarriti, M.D., from the Montefiore Medical Center and Albert Einstein College of Medicine in Bronx, New York, and colleagues examined whether presenting comorbidities in patients with COVID-19 in New York City differed by race\/ethnicity and whether case fatality rates varied by race\/ethnicity in 5,902 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presenting to the Montefiore Medical Center.<\/p>\n
The researchers found that 15.5 percent of patients died within the study time frame. The death rates were 16.2, 17.2, 20.0, and 17.0 percent for Hispanic, non-Hispanic Black, non-Hispanic White, and Asian patients, respectively. Compared with non-Hispanic White patients, a higher proportion of Hispanic and non-Hispanic Black patients had more than two medical comorbidities (34.3 and 39.5 percent, respectively, versus 28.9 percent). The likelihood of testing positive for COVID-19 was higher for Hispanic and non-Hispanic Black versus non-Hispanic White patients (65.3 and 68.5 percent, respectively, versus 53.0 percent). Compared with non-Hispanic Whites, patients identifying as Hispanic or non-Hispanic Black had slightly improved survival (hazard ratios, 0.77 and 0.69, respectively) after controlling for age, sex, socioeconomic status, and comorbidities.<\/p>\n
“These findings may provide some reassurance that access to the services available in comprehensive health care environments may attenuate, if not eliminate, racial\/ethnic differentials in COVID-19 mortality rate,” the authors write.<\/p>\n
Abstract\/Full Text<\/a><\/p>\n